Undertreatment of osteoporosis and the role of gastrointestinal events among elderly osteoporotic women with Medicare Part D drug coverage
Ethel S Siris,1 Jingbo Yu,2 Katalin Bognar,3 Mitch DeKoven,4 Anshu Shrestha,3 John A Romley,5 Ankita Modi2 1Toni Stabile Osteoporosis Center, Columbia University Medical Center, NY Presbyterian Hospital, New York, NY, 2Merck & Co., Inc., Kenilworth, NJ, 3Precision Health Economics, Los Ange...
Guardado en:
Autores principales: | Siris ES, Yu J, Bognar K, DeKoven M, Shrestha A, Romley JA, Modi A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/83f4592712ec42a1b6634728d88ef1d1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment
por: Richard Derman, et al.
Publicado: (2009) -
Treatment of osteoporosis with teriparatide: The Slovenian experience
por: Kocjan Tomaz, et al.
Publicado: (2021) -
Enfrentamiento de la osteoporosis post menopáusica en la consulta ginecológica
por: Francisco,Fuentes Q, et al.
Publicado: (2017) -
Treatment of primary osteoporosis in men
por: Giusti A, et al.
Publicado: (2014) -
Alendronate improves QOL of postmenopausal women with osteoporosis
por: Hisaya Kawate, et al.
Publicado: (2010)